![James Coulston](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Coulston
Finanzdirektor/CFO bei
PROKIDNEY CORP.
Vermögen: 1 Mio $ am 30.06.2026
Profil
James Coulston currently works at ProKidney LLC, as Chief Financial Officer from 2022 and ProKidney Corp., as Chief Financial Officer from 2022.
Mr. Coulston also formerly worked at Catalyst Biosciences, Inc., as Senior Director-Finance, Banner Life Sciences LLC, as Executive Director-Finance from 2015 to 2019, and Targacept, Inc., as Senior Director-Finance & Controller from 2007 to 2015.
Mr. Coulston received his undergraduate degree and graduate degree from North Carolina State University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PROKIDNEY CORP. 0,44 % | 08.04.2026 | 716.850 ( 0,44 % ) | 1 Mio $ | 30.06.2026 |
| 08.04.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von James Coulston
| Unternehmen | Position | Beginn |
|---|---|---|
| PROKIDNEY CORP. | Finanzdirektor/CFO | 01.01.2022 |
ProKidney LLC
 ProKidney LLC Packaged SoftwareTechnology Services Develops a medical technology that restores kidney function by using the patient’s own cells | Finanzdirektor/CFO | 01.02.2019 |
Ehemalige bekannte Positionen von James Coulston
| Unternehmen | Position | Ende |
|---|---|---|
Banner Life Sciences LLC
 Banner Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Finanzdirektor/CFO | 01.01.2019 |
Targacept, Inc.
 Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Comptroller/Controller/Auditor | 01.08.2015 |
| CATALYST BIOSCIENCES | Comptroller/Controller/Auditor | - |
Ausbildung von James Coulston
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
52
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
North Carolina State University
 North Carolina State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Banner Life Sciences LLC
Banner Life Sciences LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
ProKidney LLC
ProKidney LLC Packaged SoftwareTechnology Services Develops a medical technology that restores kidney function by using the patient’s own cells | Technology Services |
ProKidney Corp.
 ProKidney Corp. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company | Health Technology |
